Streltima 45 mg/0.5 ml
Streltima 45 mg/0.5 ml is a medicine authorised by Swissmedic under authorisation number 70527. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 September 2025 and the authorisation is limited until 30 September 2026. ATC code L04AC05 places the medicine in the group Immunosuppressants.
| Authorisation number | 70527 |
|---|---|
| Name | Streltima 45 mg/0.5 ml |
| Full name | Streltima 45 mg/0.5 ml, Injektionslösung im Fertigpen |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC05 |
| First authorisation | 30 September 2025 |
| Authorisation validity | 30 September 2026 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Streltima 45 mg/0.5 ml, Injektionslösung im Fertigpen | B | 30 September 2025 |
| 2 | Streltima 90 mg/1.0 ml, Injektionslösung im Fertigpen | B | 30 September 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Injektor(en), vorgefüllt/Pen | L04AC05 | 07.15.0. | B |
| 2 | 1 | Injektor(en), vorgefüllt/Pen | L04AC05 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Streltima 45 mg/0.5 ml authorised in Switzerland?
Yes. Streltima 45 mg/0.5 ml is authorised by Swissmedic under authorisation number 70527, data as of 01 September 2026. The authorisation is limited until 30 September 2026.
Which dispensing category does Streltima 45 mg/0.5 ml have?
Streltima 45 mg/0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Streltima 45 mg/0.5 ml?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.